11/14
05:18 pm
vrdn
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Commodore Capital LP
Medium
Report
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Commodore Capital LP
11/5
07:58 am
vrdn
Form 10-Q Viridian Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Viridian Therapeutics, For: Sep 30
11/5
07:09 am
vrdn
Form 8-K Viridian Therapeutics, For: Nov 05
Medium
Report
Form 8-K Viridian Therapeutics, For: Nov 05
10/27
04:32 pm
vrdn
Form SCHEDULE 13D/A Viridian Therapeutics, Filed by: Fairmount Funds Management LLC
Low
Report
Form SCHEDULE 13D/A Viridian Therapeutics, Filed by: Fairmount Funds Management LLC
10/27
04:31 pm
vrdn
Form 4 Viridian Therapeutics, For: Oct 23 Filed by: Fairmount Healthcare Fund II GP LLC
Low
Report
Form 4 Viridian Therapeutics, For: Oct 23 Filed by: Fairmount Healthcare Fund II GP LLC
10/23
06:04 am
vrdn
Form 424B5 Viridian Therapeutics,
Low
Report
Form 424B5 Viridian Therapeutics,
10/23
06:04 am
vrdn
Form 8-K Viridian Therapeutics, For: Oct 21
Low
Report
Form 8-K Viridian Therapeutics, For: Oct 21
10/21
04:37 pm
vrdn
Form 424B5 Viridian Therapeutics,
Medium
Report
Form 424B5 Viridian Therapeutics,
10/21
04:35 pm
vrdn
Form 8-K Viridian Therapeutics, For: Oct 21
Medium
Report
Form 8-K Viridian Therapeutics, For: Oct 21
10/20
07:43 am
vrdn
Form 8-K Viridian Therapeutics, For: Oct 17
Low
Report
Form 8-K Viridian Therapeutics, For: Oct 17